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Abstract: Boswellia serrata and Boswellia sacra (syn. B. carteri) are important medicinal plants widely used 
for their content of bioactive lipophilic triterpenes. The qualitative and quantitative determination of 
boswellic acids (BAs) is important for their use in dietary supplements aimed to provide a support for 
osteoarthritic and inflammatory diseases. We used High Performance Liquid Chromatography  
(HPLC)-Diode Array Detector (DAD) coupled to ElectroSpray Ionization and tandem Mass 
Spectrometry (ESI-MS/MS) for the qualitative and quantitative determination of BAs extracted from the 
gum resins of B. sacra and B. serrata. Limit of detection (LOD), limit of quantification (LOQ), and Matrix 
Effect were assessed in order to validate quantitative data. Here we show that the BAs quantitative 
determination was 491.20 g·kg−1 d. wt (49%) in B. sacra and 295.25 g·kg−1 d. wt (30%) in B. serrata. Lower 
percentages of BAs content were obtained when BAs were expressed on the gum resin weight (29% and 
16% for B. sacra and B. serrata, respectively). The content of Acetyl-11-Keto-β-Boswellic Acid (AKBA) was 
higher in B. sacra (70.81 g·kg−1 d. wt; 7%) than in B. serrata (7.35 g·kg−1 d. wt; 0.7%). Our results show that 
any claim of BAs content in either B. sacra or B. serrata gum resins equal to or higher than 70% or AKBA 
contents of 30% are simply unrealistic or based on a wrong quantitative determination. 
Keywords: Acetyl-11-Keto-β-Boswellic Acid; 11-Keto-beta-Boswellic Acid; boswellic acids; 
standardization; Boswellia serrata; Boswellia sacra; HPLC-DAD-ESI-MS/MS 
 
1. Introduction 
The genus Boswellia (Burseraceae), comprises 25 species of trees and shrubs which are widely spread 
in Arabia, the north-eastern coast of Africa and India [1]. Since ancient times, the natural resin of Boswellia 
trees has been collected and used to produce the oleo gum resin, frankincense (olibanum). The gum resin 
is harvested from incisions made on the trunk of the tree and the darkening of resin droplets is an index 
of oxidation [2]. Among Boswellia species, only a few are of economic importance as a natural source of 
phytopharmaceutical compounds, including B. serrata Roxb. and B. sacra Flueck (syn. B. carteri Birdw, syn. 
B. undulatocrenata Engl.) [3–5]. 
B. serrata is used for the treatment of oxidative and inflammatory damage [2], rhinitis [6] asthma [7], 
age-related disorders [8], neurorecovery [9], arthritis [10], skin disorder [11], cancer [12], and against 
several human pathogenic and plant pathogenic fungi [13]. Recently, the pharmacological properties and 
clinical effectiveness of B. serrata have been studied systematically [3]. 
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B. sacra oleo gum resin is used in the treatment of gastric and hepatic disorders [14], skin  
disorders [15], for its hepatoprotective activity [16], analgesic effect [4], antiglycation and antioxidant 
activities [17], tumor suppression [18], anticoagulation effects [19], antinflammatory activity [20], and 
cardioprotective effects [21]. 
The main constituents of B. serrata and B. sacra are volatile oils, composed of monoterpenes and 
sesquiterpenes [22,23], diterpenes including incensole, incensole acetate and cembrenol (serratol) [24], 
lipophilic pentacyclic triterpene acids of the oleanane-(α-boswellic acids), ursane-(β-boswellic acids) and 
lupane-type (lupeolic acids), as well as an ether-insoluble fraction containing polysaccharides (arabinose, 
galactose, xylose) [25]. Among triterpenoids, bioactive boswellic acids are of particular interest, 
particularly 3-O-Acetyl-11-Keto-β-Boswellic Acid (AKBA), 11-Keto-beta-Boswellic Acid (KBA), and the 
various β-boswellic acids (βBAs), and α-boswellic acids (αBAs) and their esters. The analysis of these 
triterpenes is performed by different analytical methods including High Performance Thin Layer 
Chromatography (HPTLC) [26], although the most used methods are based on HPLC coupled to both 
photodiode array detection [27] and mass spectrometry detection [28]. In accordance with the spectral 
properties of the boswellic acids, their analysis is performed at three different wavelengths, 210 nm for 
αBAs, βBAs as well as lupeolic acid, 250 nm for AKBA and KBA, and 280 nm for 9,11-dehydro-α- and  
-β-boswellic acids [27]. However, a precise identification and quantification of boswellic acids is usually 
obtained with liquid chromatography electrospray ionisation tandem mass spectrometry (LC-ESI-
MS/MS) by using selected ion monitoring (SIM) detection [28]. 
In general, the total organic acids from B. serrata and B. sacra constitute approximately 65%–70% by 
weight of the total alcoholic extract. Of this fraction, approximately 25% is made of triterpenes. In market 
products, these percentages are often misinterpreted and it is not unusual to find claims of 70% boswellic 
acids content or 30% AKBA content, which is obviously misleading because the highest amounts so far 
reported of boswellic acids in B. serrata is about 140 mg/g (i.e., 14%) and in B. sacra is about 190 mg/g (i.e., 
19%) [27]. Since both Boswellia extracts are used in several formulations, it is important to express 
unequivocally the “real content” of boswellic acids in both B. serrata and B. sacra. Therefore, the aim of this 
work is to provide a guideline for the accurate identification and quantification of boswellic acids in these 
two important Boswellia species by using HPLC-DAD-ESI-MS/MS. 
2. Results and Discussion 
2.1. Identification of Boswellic Acids 
Gum resin of B. sacra and B. serrata were extracted using methanol in order to evaluate the total BAs 
content. The total yield for B. sacra methanolic extract was 598.88 g·kg−1 (±11.40 g·kg−1) gum resin dry 
weight whereas the yield for B. serrata was 549.78 g·kg−1 (±29.31 g·kg−1) gum resin dry weight. The total 
recovery of methanolic extracts from B. sacra was 99.17% (±1.93%), whereas the total recovery from B. 
serrata was 98.96% (±1.97%). Our findings indicate that the total content of the lipophilic extracts 
(excluding the polysaccharide moiety of both species) never exceeded 60%, in agreement with previous 
works [27,29,30]. By considering that the methanolic fraction contains several lipophilic compounds, 
including mono-, di- and triterpenes, it is evident that a claim of 70% BAs is not sustainable, being the 
BAs only a portion of the total methanolic extract. 
In order to define the content and to identify the BAs present in the two Boswellia methanolic 
extracts, we performed HPLC-DAD-ESI-MS/MS analyses. Several BAs were present in both methanolic 
extracts. Table 1 reports the molecular mass and the fragmentation pattern of compounds identified in the 
methanolic extracts, whereas Figure 1 shows the chemical structure of the identified BAs. The 
identification of these compounds was achieved by both mass spectrometry and comparison with pure 
standards (see Supplementary Figure S1 for mass spectra of identified compounds and Supplementary 
Figure S2 for UV chromatograms). In both species, the main BAs were represented by AKBA, KBA, αBA, 
βBA, acetyl-αBA (A-αBA) and acetyl-βBA (A-βBA), in accordance with the literature data [2,31,32]. 
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Table 1. Molecular mass and fragmentation pattern of compounds identified in the methanolic extracts of 
B. sacra and B. serrata. 
Compounds RT (min) [Μ − Η]−(m/z) Ions (m/z) Occurrence in 
B. sacra B. serrata
1 11-Keto-Ursolic acid 24 469 451, 407, 391 x x 
2 11-Keto-β-boswellic acid 25.8 469 451, 407, 391 x x 
3 3-O-Acetyl-11-keto-β-Boswellic Acid 28.8 511 451, 361 x x 
4 3-α-Hydroxy-7,24-dien-tirucallic acid 34.5 455 453, 437, 373  x 
5 3-α-Hydroxy-8,24-dien-tirucallic acid 36.5 455 453, 437, 373 x x 
6 3-β-Hydroxy-7,24-dien-tirucallic acid 39.4 455 453, 437, 373  x 
7 3-O-Acetyl-oleanolic acid 41 497 479, 437 x x 
8 Lupeolic acid 41.6 455 437, 409  x 
9 3-O-Acetyl-ursolic acid 43.3 497 479, 437 x x 
10 α-Boswellic acid 44.5 455 437, 409, 377 x x 
11 β-Boswellic acid 45 455 437, 409, 377 x x 
12 3-O-Acetyl-α-boswellic acid 52 497 459, 437 x x 
13 3-O-Acetyl-β-boswellic acid 52.9 497 459, 437, 395 x x 
 
Figure 1 Chemical structure of the boswellic acids identified in Boswellia serrata and Boswellia sacra. 
Numbers correspond to compounds listed in Table 1. 
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2.1. Quantification of Boswellic Acids 
Table 2 shows for both species the quantitative determination of the main BAs. The total amount of 
the main BAs was statistically (p < 0.05) higher in B. sacra than in B. serrata. In B. sacra, the total amount of 
the main BAs in the methanolic extract was lower than 50% and this value was reduced to about 29% 
when the amount was considered in terms of the total gum resin dry weight (Table 2). In B. serrata the 
total content of the main BAs in the methanolic extract was lower than 30% and the value dropped to 16% 
when BAs were calculated in terms of the gum resin dry weight (Table 2). In both species, the major BAs 
were represented by αBA and βBA, in agreement with literature data [32]. A direct comparison between 
the two species shows that the contents of B. sacra AKBA (about 10 fold), αBA (1.5 fold) and βBA (1.6 fold) 
were statistically (p < 0.05) higher than in B. serrata. 
Table 2. Quantitative determination of boswellic acids in Boswellia sacra and Boswellia serrata by High 
Performance Liquid Chromatography-Diode Array Detector coupled to ElectroSpray Ionization and 
tandem Mass Spectrometry (HPLC-DAD-ESI-MS/MS), by using calibration curves from pure standards. 
Data are expressed as g·kg−1 gum resin dry weight. (Standard deviation), in the same row, different letters 
indicate significant (p < 0.05) differences. 
Compound 
Boswellia sacra Boswellia serrata 
Content in the 
Methanolic Extract 
Content in the 
Gum Resin 
Content in the 
Methanolic Extract 
Content in the 
Gum Resin 
KBA 35.50 (1.26) a 21.26 (0.76) b 34.62 (2.57) a 19.03 (1.41) c 
AKBA 70.81 (4.66) a 42.41 (2.79) b 7.35 (0.89) c 4.04 (0.49) d 
αBA 184.34 (11.27) a 110.40 (6.75) b 126.00 (7.77) b 69.27 (4.27) c 
βBA 186.19 (4.98) a 111.50 (2.98) b 113.21 (7.37) c 62.24 (4.06) c 
A-αBA 5.40 (0.35) a 3.23 (0.21) b 2.92 (0.19) b 1.60 (0.11) c 
A-βBA 9.95 (0.23) a 5.96 (0.14) b 11.33 (0.28) a 6.23 (0.15) b 
Total 491.20 (14.75) a 294.77 (8.83) b 295.25 (23.00) b 162.29 (12.64) c 
In order to validate the quantitative analyses reported in Table 2, we calculated the linearity and 
precision of the identified BAs standard curves, the detection limit (LOD), the quantification limit (LOQ) 
and the Matrix Effect (ME). Table 3 shows the validation results for the main identified BAs. All 
compounds showed a high R2 value, which indicates a high linearity in the calibration curves. The lowest 
LOD and LOQ values were found for A-βBA, followed by equal values for KBA and AKBA. The highest 
LOD and LOQ values were found for A-αBA. In order to complete the validation process, we assessed 
the ME, to assure that precision, selectivity and sensitivity were not compromised during HPLC-ESI-
MS/MS analyses. The absolute ME was calculated by comparing the slope of matrix-matched standard 
curve with the slope of the standard calibration curve, according to [33]. Table 3 reports, for each species, 
the ME accuracy (expressed as percent values) of the main identified BAs. In B. sacra extracts, KBA  
(CV = 14.06) and A-βBA (CV = 11.61) showed the highest percentage of accuracy, followed by AKBA  
(CV = 7.53) and A-αBA (CV = 1.90). βBA (CV = 8.72) showed the lowest ME accuracy percentages. In  
B. serrata, the highest percentages of accuracy were found for αBA (CV = 0.22), followed by KBA  
(CV = 14.13), A-αBA (CV = 2.66) and AKBA (CV = 7.74). 
Table 3. Validation of boswellic acids (BAs) quantitative analyses of methanolic extracts from B. sacra and 
B. serrata. (Standard deviation). 









KBA y = 13891880514x + 180215436.7 0.973 0.006 0.020 100.67 (14.17) 98.83 (13.96) 
AKBA y= 24732.09x − 143.76 0.997 0.006 0.021 99.91 (7.53) 91.53 (7.08) 
αBA y = 1349052089x + 8552264.58 0.989 0.008 0.028 88.52 (9.75) 139.80 (0.31) 
βBA y = 1549451236x + 1749204.16 0.995 0.013 0.042 73.40 (6.40) 77.25 (7.11) 
A-αBA y = 9915.15x − 127.16 0.995 0.017 0.058 93.27 (1.77) 92.91 (2.47) 
A-βBA y = 9179.53x − 101.22 0.995 0.003 0.010 100.23 (11.64) 90.70 (8.74) 
R2, coefficient of determination; LOD, Detection limit; LOQ, Quantification limit; ME, matrix effect, 
expressed as percentage of accuracy. 
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Finally, Table 4 shows the recovery of the identified BAs from B. sacra and B. serrata methanolic 
extracts. In both species, the total recovery was higher than 98%. In B. sacra, the highest recovery was 
found for AKBA and αBA, whereas in B. serrata the highest recovery was found for A-βBA and A-αBA 
(Table 4). 
Table 4. Percentage of recovery of identified BAs from B. sacra and B. serrata methanolic extracts. Values 
are expressed as percentage of recovery. 
Compounds B. sacra B. serrata 
KBA 96.53 99.06 
AKBA 99.68 96.88 
αBA 99.39 99.14 
βBA 98.75 97.13 
A-αBA 88.71 99.38 
A-βBA 91.34 99.84 
Total 98.68 98.41 
The quantitative determination of B. sacra and B. serrata BAs content and the validation of the 
quantitative chemical analysis show that any claim of BAs content in either B. sacra or B. serrata gum resins 
equal to or higher than 70% or 30% AKBA are simply unrealistic or based on a wrong quantitative 
determination. The same is true when the percentage of BAs is calculated in the methanolic extract. 
3. Materials and Methods 
3.1. Plant Material and Chemicals 
Boswellia serrata Roxb. and Boswellia sacra Flueck gum resins were purchased from Bauer S.r.l. (Udine, 
Italy). The origin of B. sacra samples was from Ethiopia, whereas B. serrata samples originated from India. 
The gum resins were milled to coarse powder and used for all extractions. All chemicals were of analytical 
reagent-grade unless stated otherwise. Pure standards were purchased for the quantification by external 
calibration curves: 11-Keto-β-boswellic acid, α-Boswellic acid and β-Boswellic acid (ExtraSynthese, Lyon, 
France), 3-O-Acetyl-11-keto-β-Boswellic Acid (Merck, Darmstadt, Germany), 3-O-Acetyl-α-boswellic 
acid, 3-O-Acetyl-β-boswellic acid (Sigma-Aldrich, St. Louis, MO. USA). 
3.2. Solvent Extraction of Boswellia serrata and Boswellia sacra oleo Gum Resins 
One hundred grams of ground B. serrata and B. sacra oleo gum-resins were extracted with 1 L 
methanol (VWR International, Radnor, PA, USA) (extraction ratio 1:10 w/v). Samples were then placed on 
an orbital shaker for 5 days in the dark. Extracts were then filtered and the resin was rinsed with  
400 mL of methanol. To evaluate the recovery of analyzed compounds, the exhaust gum resin was  
re-extracted with methanol as previously described. Samples were then concentrated by vacuum 
evaporation (Rotavapor, Büchi, Flawil, Switzerland). Concentrated extracts were then dried in a ventilated 
oven at 70 °C for 4 h. The powdered extracts were stored at room temperature in the dark until chemical 
analysis. Extractions were performed in triplicate. 
3.3. Isolation and Quantification of Boswellic Acids by HPLC-DAD-ESI-MS/MS 
Boswellic acids were identified and quantified by liquid chromatography (1200 HPLC, Agilent 
Technologies, Santa Clara, CA, USA) equipped with a reverse phase column, Luna C18 (3 µm,  
150 mm × 3.0 mm, Phenomenex, Torrance, CA, USA). B. serrata and B. sacra powdered extracts were 
dissolved (30 mg·mL−1) in HPLC-grade methanol and properly diluted. The binary solvent system was: 
A) MilliQ H2O (Millipore, Billerica, MA, USA):Methanol 50:50 containing 5 mM ammonium acetate 
(Sigma-Aldrich, USA) and B) Methanol:1-Propanol (VWR International, Radnor, PA, USA) 80:20 
containing 5 mM ammonium acetate. The chromatographic separation was carried out at constant flow 
rate (200 µL·min−1) with the following conditions: linear gradient from 30% to 50% of B in 2 min, then 80% 
of B in 35 min, then at 47 min B concentration was raised to 98%. The concentration of solvent B was 
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maintained at 98% for 6 min. The initial mobile phase was re-established for 10 min before the next 
injection. The temperature of wellplate autosempler G1377A was set 4 °C while chromatography  
was carried out at constant temperature (30 °C) controlled by an Agilent 1100 HPLC G1316A  
Column Compartment. 
Tandem mass spectrometry analyses were performed with a 6330 Series Ion Trap LC-MS System 
(Agilent Technologies, USA) equipped with an electrospray ionization source (ESI) operating in negative 
mode. The flow rate of nitrogen was set 325 °C and 5.0 L·min−1, while the Capillary Voltage was 1.5 kV. 
Helium was used as a collision gas. 
Identification of Boswellia oleo gum resin compounds was performed by scan analyses with a 50–750 
m/z scan range and by monitoring the absorption at 210, 250 and 280 nm. Quantitative analyses were 
performed by Multiple Reaction Monitoring (MRM) by monitoring the fragmentation of quasi-molecular 
ions for αBA and βBA and KBA (Table 1) and by Diode Array Detector (DAD) at 250 nm for AKBA and 
210 nm for A-αBA and A-βBA. Quantification was performed by external calibration curves with pure 
standards dissolved in HPLC grade Methanol. Limit of Detections (LOD) and Limit of Quantifications 
(LOQ) for each compounds were determined as described in [34]. 
To evaluate the ME in the quantification of target compounds, B. serrata and B. sacra powdered 
extracts were dissolved (30 mg·mL−1) in HPLC-grade methanol and properly diluted. These sample 
solutions were used to prepare the calibration curves in the presence of other extracted gum resin 
compounds [33]. The slope of standard curves obtained with the solvent (methanol) and in the extracts 
were used to compare the ME percentage (%ME = Calibration Slope(sample)/CalibrationSlope(standard) × 100). 
100% ME percentage indicates no ME, a ME% < 100% indicates ionization suppression and a ME% > 100% 
indicates ionization enhancement. 
4. Conclusions 
Boswellia sacra and Boswellia serrata extracts are widely used in pharmaceutical and nutraceutical 
preparations. The bioactivity of these Boswellia extracts is based on the content of BAs. Clearly, the dose of 
bioavailable BAs is central to the issue of Boswellia efficacy. Claims of 70% BAs or even 30%–40% AKBA 
are currently found, but this work confirms that the BAs content never exceeds 50% of the methanolic 
extract, whereas lower percentages are obtained when BAs are expressed in terms of the gum resin 
weight. Moreover, the highest percentage of AKBA found in B. sacra was below 8%. Only analytical 
methods based on HPLC coupled to mass spectrometry allow the precise quantification and identification 
of BAs in Boswellia extracts, whereas other methods based only on HPLC or spectrophotometric methods 
do not sufficiently allow an accurate quantification of BAs. Therefore, we recommend LC-MS technology 
for BAs determination and quantification. 
Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/21/10/1329/s1, 
Figure S1: mass spectra of boswellic acids isolated in this study; Figure S2: UV chromatograms of boswellic acids 
isolated in this study. 
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